Is Braak staging valid for all types of Parkinson's disease?

被引:82
作者
Jellinger, Kurt A. [1 ]
机构
[1] Inst Clin Neurobiol, Alberichgasse 5-13, A-1150 Vienna, Austria
关键词
Braak staging; Parkinson's disease; Lewy body disease; Guidelines; Lewy pathology; ALPHA-SYNUCLEIN PATHOLOGY; INCIDENTAL LEWY BODY; AUTONOMIC NERVOUS-SYSTEM; OBLIGATORY TRIGGER SITE; DORSAL MOTOR NUCLEUS; NIGRAL NEURONAL LOSS; BRAIN PATHOLOGY; DEMENTIA; BODIES; NEUROPATHOLOGY;
D O I
10.1007/s00702-018-1898-9
中图分类号
R74 [神经病学与精神病学];
学科分类号
100204 [神经病学];
摘要
Braak et al. proposed that cases with Lewy pathology in the peripheral nervous sytem, spinal cord and brain stem are prodromal Parkinson's disease (PD), suggesting a hypothesized progression of PD pathology. However, the putative potential of peripheral alpha-synuclein to promote brain pathology has been questioned recently. The Braak staging is a matter of vigorous debate, since < 100% of cases with Lewy pathology fitting the proposed PD staging scheme; however, most studies assessing typical PD cases show that the vast majority (80-100%) fit the Braak staging scheme. Incidental Lewy body disease and PD can show Lewy pathology in substantia nigra or other brain areas without involvement of dorsal motor nucleus of the vagus nerve. The Braak staging system is valid for PD patients with young onset, long duration with motor symptoms, but not for others, e.g., late onset and rapid course PD. The validity of Braak staging and its relationship to various subtypes of PD warrants further studies.
引用
收藏
页码:423 / 431
页数:9
相关论文
共 98 条
[71]
Relationship among α-synuclein accumulation, dopamine synthesis, and neurodegeneration in Parkinson disease substantia nigra [J].
Mori, Fumiaki ;
Nishie, Makoto ;
Kakita, Akiyoshi ;
Yoshimoto, Makoto ;
Takahashi, Hitosh ;
Wakabayashi, Koichi .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2006, 65 (08) :808-815
[72]
Müller CM, 2005, J NEUROPATH EXP NEUR, V64, P623
[73]
O'Keeffe G. W., 2018, PARKINSONISM RELAT D
[74]
Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease [J].
Orimo, Satoshi ;
Takahashi, Atsushi ;
Uchihara, Toshiki ;
Mori, Fumiaki ;
Kakita, Akiyoshi ;
Wakabayashi, Koichi ;
Takahashi, Hitoshi .
BRAIN PATHOLOGY, 2007, 17 (01) :24-30
[75]
Regional distribution of α-synuclein pathology in unimpaired aging and Alzheimer disease [J].
Parkkinen, L ;
Soininen, H ;
Alafuzoff, I .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (04) :363-367
[76]
Applicability of current staging/categorization of α-synuclein pathology and their clinical relevance [J].
Parkkinen, Laura ;
Pirttila, Tuula ;
Alafuzoff, Irina .
ACTA NEUROPATHOLOGICA, 2008, 115 (04) :399-407
[77]
Disentangling the Relationship between Lewy Bodies and Nigral Neuronal Loss in Parkinson's Disease [J].
Parkkinen, Laura ;
O'Sullivan, Sean S. ;
Collins, Catherine ;
Petrie, Aviva ;
Holton, Janice L. ;
Revesz, Tamas ;
Lees, Andrew J. .
JOURNAL OF PARKINSONS DISEASE, 2011, 1 (03) :277-286
[78]
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration [J].
Peelaerts, W. ;
Bousset, L. ;
Van der Perren, A. ;
Moskalyuk, A. ;
Pulizzi, R. ;
Giugliano, M. ;
Van den Haute, C. ;
Melki, R. ;
Baekelandt, V. .
NATURE, 2015, 522 (7556) :340-+
[79]
Peelaerts W, 2018, CELL TISSUE RES
[80]
Peng C, 2018, NATURE